Search News

Corporate Industry Technology Medical Updates

MoyoAssist® Extra-VAD

Medical Updates
The FIRST transseptal cannulation treatment via MoyoAssist Extra-VAD 2022-08-24
Technology
magAssist participation in the 9th World Congress of Biomechanics 2022 2022-07-10
Corporate
2021 BlackBOX Melbourne X magAssist: A Collision between Design and Innovation 2021-12-28
Technology
magAssist receives keen international attention at the 47th European Society for Artificial Organs Congress 2021-09-13
Industry
Dr. Po-Lin Hsu and her "Heart" of magAssist 2020-05-10
Corporate
magAssist Attains Recognition as the Most Innovative Medical Device Product of 2023 2023-08-21
Corporate
MoyoAssist® Extra-VAD, a Promising Solution for Short-to-Medium-Term Ventricular Assist for China NMPA trial, Showcased at 4th Academic Annual Conference of CSBE 2023-06-17
Corporate
magAssist Revealed in MedTech Outlook's Top 10 MedTech Companies in APAC Region for 2022 2023-03-14
Corporate
magAssist Gains Recognition for Its Innovation in the Cardiovascular Field at 2022 Critical Heart Disease Congress-International Society for Mechanical Circulatory Support Parallel Forum 2023-01-16
Technology
Professor Nianguo Dong of Wuhan Union Hospital Gives Speech Entitled “Clinical Experience with the MoyoAssist® Extracorporeal Ventricular Assist Device” 2023-01-06

Tabs： heart disease, extracorporeal ventricular assist device, medtech Innovator, BreathMo, end-stage heart failure, minimally invasive pVADs, clinical scenarios, innovative medical device enterprises in China, Heart Failure Treatment, Po-Lin Hsu,